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Abstract Objective To explore the relationship between sudden sensorineural hearing loss（SSNHL）and vascular
risk factors（including serum lipids and uric acid）. Method This is a retrospective analysis of 100 cases of SSNHL
seen at the Drum Tower Hospital, Nanjing Medical University, between Jan. 2007 and Apr. 2008。Patient history,
blood test results and imaging scans were analyzed. Levels of triglyceride（TG）, cholesterols（CHO）, high density
lipoprotein-cholesterol（HDL-CH）, low density lipoprotein-cholesterol（LDL-CH）, apolipoprotein AI（ApoAI）,
apolipoprotein B（ApoB）and uric acid（UA）from these patients were compared with a control group of 56 patients
treated for vocal cord polyps or nasal septum deviation during the same period. Patients with hypertension, diabetes,
heart, brain, liver or kidney disorders are excluded from the present investigation. Results HDL-CH level was
higher and UA level lower in the study group than the control group（P< 0.05）. HDL-CH and UA showed no
significant differences among different age-groups（P> 0.05）. There were no significant differences in the levels of
TG, CHO, LDL-CH, ApoAI and ApoB（P> 0.05）. Conclusion These data indicate that metabolic disturbances of
serum lipids and/or uric acid may be potential risk factors for SSNHL
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Introduction
Sudden sensorineural hearing loss（SSNHL）has been
defined as sensorineural hearing loss of 20 dB over at
least 3 contiguous audiometric frequencies, occurring
within 3 days［1］. Approximately15, 000 new cases of
SSNHL occur annually worldwide, accounting for 1% of
all cases of sensorineural hearing loss［2,3］. Being a typi⁃
cal acute（mostly unilateral）inner ear disorder with un⁃
known etiology, SSNHL is assumed to be a multi-factori⁃
al disorder with different underlying etiologies. At pres⁃
ent, SSNHL remains one of the refractory diseases to
otologist. Efforts by many experts to find its causes have
failed to yield results. Etiologies can be identified in
about 10-15% of all cases, including microcirculatory
disturbance, infection, autoimmune disorders, but the
majority of cases are idiopathic. Microcirculation distur⁃
bance in the cochlea as the cause of SSNHL has always
been a research hotspot. The deep position of the co⁃
chlea within the temporal bone makes it difficult to di⁃
rectly study cochlear microcirculation disturbance or
embolism in SSNHL patients. But there seem to be simi⁃
larities between cochlear microcirculation disturbance
and cardio- or cerebrovascular embolism.
In recent years, many studies have been directed to
evaluating the role of various cardiovascular risk factors
and blood vessel embolism in SSNHL［3-7］. High serum-
cholesterol, anticardiolipin antibodies, plasminogen acti⁃
vator inhibitor, blood plasma viscosity, increased fibrino⁃
gen, and decreased red blood cell filtration rate have
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been suggested to be associated with SSNHL, although
not without controversies［5，6］. Uric acid, as purine metab⁃
olites, can stimulate proliferation of vascular smooth
muscle cell and generation of local thronboxane after en⁃
tering the cell［8］, with possible effects on the process of
cochlear microvascular embolization. The present study
is aimed at studying the relationship between SSNHL
and vascular risk factors through retrospective case anal⁃
ysis.
1 Material and Methods
1.1 Subjects
1.1.1 SSNHL Group
Subjects were 100 patients seen at the Department
of Otolaryngology-Head and Neck surgery, the Affiliat⁃
ed Drum Tower Hospital of Nanjing Medical University
between Jan. 2007 and Apri.2008 with a diagnosis of
SSNHL. There were 50 males and 50 females in this
group with a mean age of 42.23 years（ranging from 15
to 69 years）. Diagnosis of SSNHL was made based upon
the criteria established at Jinan Conference［1］. All cases
were unilateral, of which 50 were on right ears and 50
on left. All patients underwent complete audiometric
evaluation. Evaluation also included detailed history,
physical examination, imaging studies and blood tests.
Collected history covered time interval between onset of
hearing loss and hospital admission, associated symp⁃
toms, emotional disturbances and demographic informa⁃
tion including occupation. Body weight was also taken.
1.1.2 Control Group
he control group included 56 patients treated for na⁃
sal septum deviation or vocal cord polyps during the
same period of time as the SSNHL patients. There were
30 males and 26 females with a mean age of 33 years
（ranging from 17 to 60 years）. All individuals in this
group had normal hearing
Exclusion criteria included diseases such as hyperten⁃
sion, diabetes mellitus, cardiac or cerebral diseases, liv⁃
er and kidney diseases, and neoplasm.
1.2 Methods
1.2.1 Blood test indices
Fasting venous blood specimens were sent to the labo⁃
ratory for testing. Levels of triglyceride（TG）, cholesterol
（CHO）, high density lipoprotein-cholesterol
（HDL-CH）, low density lipoprotein-cholesterol
（LDL-CH）, apolipoprotein AI（ApoAI）, apolipoprotein
B（ApoB） and uric acid（UA） were tested. Patients
were divided into four age groups（≤20, 21-40, 41-60,
and >60）.
1.2.2 Statistical Analysis
Covariance analysis was conducted using the
SPSS10.0 software. Statistical significance was accepted
when p < 0.05.
2 Results
2.1 Subject population
Of the 100 patients, 56% had office jobs, 35% were
manual laborers and 9% were in non-specified profes⁃
sions. Events at the onset of SSNHL included fatigue
（71.43%）, mood changes（84%）, and life style changes
（16%）such as smoking and drinking. Associated symp⁃
toms included vertigo（51%）, tinnitus（96%）, nausea
（34%）, and vomiting（24%）. The average Body Mass in⁃
dexes（BMI）was 22.10 ± 2.38 kg/m2 in the control group
and 22.30 ± 2.27 kg/m2 in study patients, respectively
（t= 0.62）.
2.2 Serum Lipid and Uric Acid
Table 1 shows results of the tested parameters. Be⁃
cause age distribution was different between SSNHL pa⁃
tients and the control group（t = 0.000）, age factor was
not included in the disease-control comparison analy⁃
sis. Covariance analysis was used to mitigate the influ⁃
ence of age factor. When compared between the two
groups, the differences of HDC-CH and UA levels
reached statistical significance（p=0.0010 and p=
0.0008, respectively）, and those of the rest indexes did
not.
The combined 156 cases were divided into 4 age
groups（see methods）and one-factor analysis of vari⁃
ance was used to test influence of age on the indexes.
The comparison among the age groups showed no statis⁃
tically significant differences with HDL-CH, LDC-CH,
ApoAI, ApoB and UA（p > 0.05）, indicating no age ef⁃
fects on lipid or UA metabolism.
3 Discussion
The pathogenesis of SSNHL remains unknown, and is
generally believed to be related with virus infection and
vascular embolism. There are numerous factors affecting
cochlea microcirculation and many studies have focused
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on the mechanism of its disturbance recently. However,
the studies have been inconclusive. As one of the risk
factors for atherosclerosis, hypercholesterolemia contrib⁃
utes to heart/brain/aorta occlusion. Similar effects on the
cochlear ischemia-reperfusion injury from hypercholes⁃
terolemia have been suspected. Marcucci and his col⁃
leagues［4］ concluded that hypercholesterolemia was an
independent risk factor for SSNHL through his study on
the relationship between SSNHL and risk factors for car⁃
diovascular and thrombosis. LU Yuan-yuan's research
［7］ showed that Total CHO, TG, and lipoprotein A in
SSNHL group were higher than the control group.
Gabriella Cadoni and his colleagues［9］ were
not able to confirm the association between congenital
and acquired thrombus risk factors and SSNHL. Like⁃
wise, Claudia Rudack and his colleagues［10］ found no
correlation between HDL，CHO，LDL and CHO and
SSNHL. Our study shows that total CHO was not differ⁃
ent between the SSNHL and control groups, but the
HDL-CH level in SSNHL group was lower than the con⁃
trol group. HDL-CH is a type of CHO carried by HDL
and indirectly reflects HDL levels. It is well known that
HDL drives CHO to counter transport, eliminates extra
cholesterol from blood and organs and eventually slows
the process of atherosclerosis［11］. HDL can also reverse
endothelial dysfunction, inhibit LDL oxidation, stimu⁃
late endothelial cell proliferation and prostacyclin gener⁃
ation（a vasodilative and anti-thrombosis agent）, reduce
platelet aggregation ［12］, and much more. Lowered HDL
levels diminish these benefits and increase the risk for
thrombosis. Improved therapeutic results have been re⁃
ported when blood lipoid adjustment is included in the
SSNHL treatment protocol, probably from decreased co⁃
chear ischemia-reperfusion injury［13］and blood viscosity
［14，15］.
The higher blood UA level in the SSNHL group than
the control group seen in this study suggests a possible
relationship between UA and SSNHL. Increased blood
UA level may lead to UA deposits in vascular intima, re⁃
sulting in local damage and inflammation, aggravated ar⁃
teriosclerosis and accelerated formation of thrombosis
［16］. However, some researchers insist that UA is the
most important antioxidant in blood that can prevent
cells from tyrosine residue nitration and prevent extra⁃
cellular superoxide dismutase from degradation［17］, thus
exerting protective effects in heart and cerebral vascular
conditions.
More than 80% of our patients experienced signifi⁃
cant mood swings at the onset of SSNHL, similar to re⁃
ports by Jae-Ho Ban and Yuan-yuan Lu［6，18］. Job pres⁃
sure, emotional and physical stress can lead to anxiety,
overexcitation in the nervous system and excessive re⁃
lease of catecholamine, which in turn may result in in⁃
ner ear vasospasm, increased platelet aggregation and a
tendency to thrombosis.
In conclusion, our study indicates a relationship be⁃
tween the occurrence of SSNHL and a number of vascu⁃
lar risk factors including blood lipids and uric acid me⁃
tabolism disorder. Further studies are needed to investi⁃
gate pathopoiesis of HDL-C and UA in SSNHL.
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Item（unit）
TG（mmol/L）
CHO（mmol/L）
HDC-CH（mmol/L）
LDC-CH（mmol/L）
ApoAI（g/L）
ApoB（g/L）
UA（umol/L）
SSNHL Group
1.13±0.80
4.41±0.98
1.12±0.31
2.34±0.73
1.35±0.32
0.76±0.26
332.02±74.96
Control Group
1.39±0.90
4.11±1.00
1.30±0.29
2.18±0.66
1.19±0.26
0.76±0.36
284.73±91.15
Fvalue
3.49
0.23
11.22
0.26
0.48
0.00
7.24
Pvalue
0.0638
0.6320
0.0010
0.6094
0.4907
0.9901
0.0080
Table 1 Comparison between the SSNHL and control groups（x±s）
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